HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intraventricular immune checkpoint inhibition with nivolumab in relapsed primary central nervous system lymphoma.

AuthorsLeon D Kaulen, Christoph Gumbinger, Felix Hinz, Tobias Kessler, Frank Winkler, Martin Bendszus, Felix Sahm, Wolfgang Wick
JournalNeuro-oncology advances (Neurooncol Adv) 2022 Jan-Dec Vol. 4 Issue 1 Pg. vdac051 ISSN: 2632-2498 [Electronic] England
PMID35571985 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: